PS Ratio
147.97
-13.30-8.25%
Fri, 07 Feb 2025 22:50:50 GMT
Summary
- As of February 8, 2025, CLDX price to sales ratio is 147.97, with a fall of -13.30 (-8.25%) during the most recent trading day.
- Over the past year, CLDX PS ratio has dropped by -143.67 (-49.26%).
- CLDX PS ratio is now -93.06% below its all-time high of 2132.57.
Performance
CLDX PS Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PS Ratio Formula
P/S = Market capitalization
TTM Revenue
Market capitalization
TTM Revenue
TTM Revenue
CLDX PS Ratio Trends
| PeriodPeriod | PS ratioPS ratio | PricePrice | Market capMarket cap | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -8.3% | -8.3% | -8.3% | +20.2% |
| 1 m1 month | -19.4% | -19.4% | -19.4% | - |
| 3 m3 months | -15.9% | -15.9% | -15.9% | +20.2% |
| 6 m6 months | -43.3% | -31.9% | -31.9% | - |
| ytdytd | -11.9% | -11.9% | -11.9% | - |
| 1 y1 year | -49.3% | -38.1% | -26.5% | +44.9% |
| 5 y5 years | +1248.9% | +863.2% | +3665.2% | +179.2% |
CLDX PS Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -19.4% | 147.97 | at low | |
| 3 m | 3-month | 190.60 | -22.4% | 147.97 | at low |
| 6 m | 6-month | 330.00 | -55.2% | 147.97 | at low |
| 1 y | 1-year | 477.35 | -69.0% | 147.97 | at low |
| 3 y | 3-year | 2132.57 | -93.1% | 147.97 | at low |
| 5 y | 5-year | 2132.57 | -93.1% | 5.85 | +2429.4% |
| alltime | all time | 2132.57 | -93.1% | -41.22 | +459.0% |
Celldex Therapeutics PS Ratio History
| Date | Value |
|---|---|
| 2025 | 147.97(-11.9%) |
| 2024 | 167.92(-47.9%) |
| 2023 | 322.00(-63.9%) |
| 2022 | 892.55(+129.9%) |
| 2021 | 388.15(+314.9%) |
| 2020 | 93.55(+783.4%) |
| 2019 | 10.59(+181.6%) |
| 2018 | 3.76(-87.8%) |
| 2017 | 30.87(-50.9%) |
| 2016 | 62.88(-77.7%) |
| 2015 | 282.32(-38.1%) |
| 2014 | 455.96(-13.2%) |
| 2013 | 525.58(+1263.4%) |
| 2012 | 38.55(+210.6%) |
| 2011 | 12.41(+340.1%) |
| 2010 | 2.82(-71.1%) |
| 2009 | 9.75(-41.9%) |
| 2008 | 16.77(-36.5%) |
| 2007 | 26.39(-76.1%) |
| 2006 | 110.54(+144.9%) |
| Date | Value |
|---|---|
| 2005 | 45.14(+111.7%) |
| 2004 | 21.32(-44.3%) |
| 2003 | 38.27(+276.3%) |
| 2002 | 10.17(-86.0%) |
| 2001 | 72.44(-85.9%) |
| 2000 | 514.81(+520.2%) |
| 1999 | 83.01(+139.9%) |
| 1998 | 34.60(-30.7%) |
| 1997 | 49.95(+85.3%) |
| 1996 | 26.96(+78.2%) |
| 1995 | 15.13(+148.4%) |
| 1994 | 6.09(-58.0%) |
| 1993 | 14.50(+58.1%) |
| 1992 | 9.17(-46.4%) |
| 1991 | 17.10(+581.3%) |
| 1990 | 2.51(-46.9%) |
| 1989 | 4.73(+69.5%) |
| 1988 | 2.79(-63.8%) |
| 1987 | 7.71(-75.0%) |
| 1986 | 30.85 |
FAQ
- What is Celldex Therapeutics price to sales ratio?
- What is the all time high PS ratio for Celldex Therapeutics?
- What is CLDX price to sales ratio year-to-date change?
- What is Celldex Therapeutics PS ratio year-on-year change?
What is Celldex Therapeutics price to sales ratio?
The current PS ratio of CLDX is 147.97
What is the all time high PS ratio for Celldex Therapeutics?
Celldex Therapeutics all-time high price to sales ratio is 2132.57
What is CLDX price to sales ratio year-to-date change?
Celldex Therapeutics price to sales ratio has changed by -19.95 (-11.88%) since the beginning of the year
What is Celldex Therapeutics PS ratio year-on-year change?
Over the past year, CLDX price to sales ratio has changed by -143.67 (-49.26%)